
Symbol Search

or enter GC* - Gold Futures

Quotes and Charts

YOU ARE HERE: Stocks » Quotes and Charts » News Headlines

Exact Sciences Corp. (EXAS)

10.76+0.14 (+1.32%) 4:10P EDT (NASDAQ) - [After Hours: 10.75-0.01 (-0.09%) 4:13P EDT]

Price Quote as of Tuesday, May 21st, 2013

Latest Exact Sciences Corp. (EXAS) Headlines

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Exact Sciences Is Up 16.7% (EXAS)

Comtex SmarTrend(R) - Mon May 20, 11:47AM CDT

When Exact Sciences (NASDAQ:EXAS) reported earnings two weeks ago on May 1st, 2013, analysts, on average, expected the company to report a loss of $0.20 on sales of $1.0 million. The company actually reported a loss of $0.17 per share on sales of $1.0 million, beating EPS estimates by $0.03 and matching revenue estimates. Since the company's report, shares of Exact Sciences have risen from $9.05 to $10.56, representing a gain of 16.7% in the past 19 days. (full story)

Exact Sciences to Participate in May Investor Conferences

Business Wire - Fri May 03, 9:30AM CDT

Exact Sciences Corp. (Nasdaq: EXAS) today announced that Kevin T. Conroy, the company's president and chief executive, will present at three investor conferences during May. (full story)

SGMO, JBSS, EXAS, NSH, ASRV, SRDX Are Seasonally Ripe To Go Down In the Next Five Weeks

M2 - Wed May 01, 6:53AM CDT

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of SANGAMO BIOSCIENCES, INC. (NASDAQ:SGMO), John B Sanfilippo & Son Inc (NASDAQ:JBSS), Exact Sciences Corp (NASDAQ:EXAS), Nustar GP Holdings LLC (NYSE:NSH), Ameriserv Financial Inc (NASDAQ:ASRV), SurModics Inc (NASDAQ:SRDX) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: (full story)

Exact Sciences Reports First-Quarter 2013 Financial Results, Announces Addition to Board of Directors

Business Wire - Wed May 01, 6:30AM CDT

Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter ended March 31, 2013. (full story)

Molecular Diagnostics in Cancer Testing Report: 2013 Edition

M2 - Tue Apr 30, 6:38AM CDT

Research and Markets has announced the addition of the "Molecular Diagnostics in Cancer Testing" report to their offering. Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. This TriMark Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular (full story)

Exact Sciences to Host First-Quarter 2013 Results Webcast and Call

Business Wire - Fri Apr 26, 12:15PM CDT

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a webcast and conference call to discuss its first-quarter 2013 financial results on May 1, 2013. (full story)

Nasdaq stocks posting largest percentage decreases

AP - Tue Apr 23, 5:04PM CDT

NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: (full story)

Nasdaq stocks posting largest percentage decreases

AP - Tue Apr 23, 12:27PM CDT

NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.: (full story)

LXRX, EXAS, SNTA, ASIA, SPPI, VTNC Expected To Be Down Before Next Earnings Releases

M2 - Tue Apr 23, 5:57AM CDT

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), Exact Sciences Corp (NASDAQ:EXAS), Synta Pharmaceuticals Corp (NASDAQ:SNTA), Asiainfo Linkage Inc (NASDAQ:ASIA), Spectrum Pharmaceuticals Inc (NASDAQ:SPPI), VITRAN CORP INC (NASDAQ:VTNC) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are (full story)